Enlarge / A vaccine syringe and vial in front of the GSK (GlaxoSmithKline) logo. (credit: Getty | Anadolu Agency) After its own COVID-19 vaccine setback, GlaxoSmithKline has inked a $180 million deal to help German biotech CureVac manufacture 100 million doses of its mRNA vaccine, which is currently under development. The deal also lays the […]
